TELA Bio TELA
NASDAQ TELA
$0.91 -0.01 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

TELA Bio (TELA) Net Margin (2018 - 2026)

TELA Bio (TELA) posted Net Margin of 58.38% for Q2 2026, up 9.34% on a QoQ basis from 64.39% in Q1 2026, and down 925.0% year-over-year from 7.08% in Q2 2025.

Analysis

TELA Bio (TELA) Net Margin (2018 - 2026) Analysis & Trends

TELA Bio has reported Net Margin for 9 years, with the latest figure at 58.38% in Q2 2026.

  • On a quarterly basis, Net Margin fell 925.0% year-over-year to 58.38% in Q2 2026; TTM through Jun 2026 was 41.8%, a 1333.0% increase from a year earlier, with the FY2025 full-year figure at 38.68%, up 551.0% from the prior year.
  • Net Margin was 58.38% for Q2 2026 at TELA Bio, up from 64.39% in the prior quarter.
  • The five-year high for Net Margin was 6.05% in Q4 2025, with the low at 130.66% in Q1 2022.
  • Average Net Margin over 5 years is 70.53%, with a median of 70.45% recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Net Margin soared 7087 bps in 2024, then sank 2672 bps in 2025.
  • Over 5 years, Net Margin stood at 91.32% in 2022, then grew by 12 bps to 80.14% in 2023, then rose by 30 bps to 56.47% in 2024, then soared by 89 bps to 6.05% in 2025, then slumped by 865 bps to 58.38% in 2026.
  • The last three Net Margin figures came in at 58.38% (Q2 2026), 64.39% (Q1 2026), and 6.05% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 7.37%
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 28.46%
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 15.17%
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 19.37%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 16.67%
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 13.87%
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 19.04%
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 13.47%
10 TELA Bio 50.22 Mn 19.80 Mn 13.94 Mn -58.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -58.38%
Mar 31, 2026 -64.39%
Dec 31, 2025 -6.05%
Sep 30, 2025 -41.58%
Jun 30, 2025 -49.13%
Mar 31, 2025 -60.82%
Dec 31, 2024 -56.47%
Sep 30, 2024 -54.71%
Jun 30, 2024 -78.30%
Mar 31, 2024 -34.10%
Dec 31, 2023 -80.14%
Sep 30, 2023 -76.50%
Jun 30, 2023 -80.45%
Mar 31, 2023 -104.96%
Dec 31, 2022 -91.32%
Sep 30, 2022 -94.26%
Jun 30, 2022 -107.35%
Mar 31, 2022 -130.66%
Dec 31, 2021 -102.41%
Sep 30, 2021 -106.34%